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Abstract   
There are growing concerns about the increasing trends of emerging micropollutants in the 
environment due to their potential negative impacts on natural ecosystems and humans. 
This has attracted attention from both governmental and non-governmental 
organisations worldwide. Pharmaceuticals, personal care products, and endocrine disruptors 
are continuously being released consciously or unconsciously into water sources due to 
poor regulatory frameworks especially in the developing countries. The effects of these 
contaminants are poorly known. They are not easily biodegradable and have become an 
environmental nuisance and public health issue. This has heightened the risk of exposure to 
their deleterious effects in such countries where the majority of the population are still 
struggling to have access to good quality drinking water supplies and better sanitation. With 
the rising fear of short- and long-term impacts of the ever-increasing number of persistent 
recalcitrant organic compounds accumulating in the environment, their removal is gradually 
becoming an issue to the water treatment industry. Hence, there is a need to develop 
functional techniques for the management of water contaminated by these emerging 
contaminants so as to increase the availability and access to safe and good-quality drinking 
water. We conducted a narrative review on these emerging micropollutants and 
examined their various documented sources, effects, as well as recent techniques for their 
effective removal. This becomes necessary due to the increasing occurrence of these 
pollutants in the aquatic and terrestrial environment. These levels are expected to further 
increase in the coming years as a consequence of the ever-increasing population density 
which undoubtedly characterizes developing economies. Our findings show that the 
present reported treatment techniques in the literature such as biological 
oxidation/biodegradation, coagulation/flocculation, ozonation, el ectrodialysis, 
reverse osmosis, sedimentation, filtration, and activated carbon were not designed for 
removal of these newly identified contaminants, and as such, the techniques are not 
sufficient and unable to completely degrade the compounds. We therefore 
recommended the need for concerted efforts to develop better techniques, especially 
combined advanced oxidative methods to address the shortcomings of and growing 
challenge to current practices. 
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1 Introduction 
The importance of good-quality, potable water to human existence cannot be 
underestimated, and life will be practically impossible or difficult without the availability of 
safe drinking water (Swaminathan et al. 2013; Cortés Muñoz et al. 2013). Over the last few 
decades, there have been tremendous improvements in the supply of safe drinking water to 
growing populations. This is through various governmental interventions especially in 
developing countries that want to meet the Millennium Development Goal target of 2015 
adopted by United Nations in 2000. This mandate is in line with European Commission 
Water Framework Directive article 4 that states that all commun ity w at ers s uch a s s 
urface, ground, transitional, and coastal must be in good status by 2015 (Belgiorno et al. 
2007). However, good-quality drinking water is being threatened as a consequence of various 
natural and anthropogenic inputs involving the discharge of effluents containing priority and 
emerging micropollutants that are ubiquitous in different receiving water sources. The 
emerging contaminants include persistent organic pollutants, micro-constituents, 
cyanotoxins, pesticides and herbicides, disinfection by-products, endocrine-disrupting 
chemicals (EDCs), pharmaceuticals and personal care products (PPCPs), and a host of other 
compounds. The rapid technological advancement, rapid increase in human population, 
inadequate wastewater treatment facilities, poor agricultural practices, inadequate land-use 
acts, and rapid urbanization coupled with drought occasioned by global climate change 
have created water pollution problems on a level that have not been seen before (Mara 
2003; Moore et al. 2003; Montgomery and Elimelech 2007; Johnson et al. 2008). 
Almost every industrial process involves the production and release of huge quantities of 
half a dozen or more of those mentioned pollutants in one form or the other into the 
aquatic and terrestrial environment. The most frequent occurrence is the increasing 
accumulation of pharmaceuticals and endocrine-disrupting compounds that have 
overloaded and tainted the various receiving water bodies (Lindqvist et al. 2005; 
Kasprzyk-Hordern et al. 20 09 ). The b uild-up a nd detection o f h igh concentrations 
of these micropollutants in aquatic environments has made water unsafe for aquatic 
animals and for human consumption (Moldovan 2006; Roberts and Thomas 2006; 
Tamtam et al. 2008; Liu et al. 2009). The number of these emerging contaminants is still 
expected to increase in treated wastewater due to higher population density. This has 
resulted in growing public health risks in the developing countries where impacts have been 
noted such as endocrine conduit disturbance in aquatic organisms, brain damage, 
convulsion, carcinogenic diseases, reproductive behavioral disorder, cardiovascular disease, 
liver damage, and lung defects as well as disturbances in gene expression resulting in 
feminization of aquatic organisms (Mastin 2005; Samir et al. 2006; Campbell et al. 2006; Ha 
et al. 2007; Diamanti-Kandarakis et al. 2009). The current scenario has become worse due to 
the lack of adequate and efficient water treatment facilities capable of effectively eliminating 
and degrading the toxic and recalcitrant compounds to harmless substances (Nakada et al. 
2006; Gulkowska et al. 2008; Sui et al. 2010). The deterioration of water quality seriously 
affects economic progress and impacts negatively on the sustainable development of a nation 
(Rahman et al. 2009a, b). Therefore, in order to have a healthy population and better 
society with a consequential effect on the economy growth and sustainability, access to safe 
drinking water and functional wastewater treatment facilities should not be compromised. 
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Within the last 10–15 years, different analytical techniques for the detection and 
quantification of persistent organic contaminants at environmentally low concentrations 
have been developed (Ternes and Joss 2006). This was as a consequence of the 
increasing discovery of PPCPs/EDCs in environmental matrices (Kolpin et al. 2002; Tixier et 
al. 2003; Ashton et al. 2004). Authors such as (Yoon and Lueptow 2005) and (Yoon et al. 
2006a, b) separately observed that high pollution levels in the aquatic environment were 
majorly attributed to the presence of low concentrations of EDCs and PPCPs 
(nanograms per liter). Although the effect of these compounds on human beings is still under 
debate, their presence called for caution regarding their chemical perseverance, 
microbial resistance, and synergistic effects. The degradation and removal of 
PPCPs/EDCs in aqueous solution therefore requires different techniques which are very 
diverse. Different destructive methods that allow the efficient elimination of the pollutants 
from an aqueous form could be chosen. But recent reports suggested that more than one 
treatment technique may be required to degrade these compounds, depending on the nature of 
target compounds. The risk posed by these emerging micropollutants on humans and the 
environment requires further investigation. Therefore, it becomes imperative to improve 
on the existing techniques used to remove and degrade these chemicals in the natural 
ecosystems, most essentially in drinking water, as fast as possible. To date, a review of the 
related literature indicated that there is little or no information regarding the use of 
combined advanced oxidation processes to remove pharmaceuticals and endocrine 
disrupting compounds from aqueous solutions. 
 
2 Pharmaceutical and Personal Care Products 
Pharmaceuticals are any synthesized chemicals compounds or drugs designed to cure 
and prevent the spread of diseases as well as adding value to humans and animals life (Maletz 
et al. 2013) while personal care products encompasses cosmetics, fragrances, 
preservatives, and toiletries (Houtman 2010). Pharmaceuticals include antibiotics, 
anti-diabetics, anti-epileptic, antimicrobials, anti-anxiety medications, etc. Personal care 
product includes shampoos, toiletries, toothpaste, perfume, deodorants, etc. Pharmaceutical 
and personal care products (PPCPs) are chemical compounds that have been the subject 
of discussion among scientists and the general public especially in the developed countries 
such as China, USA, Germany, and European Union since the early 1990s (Ternes et al. 2004; 
Ternes and Joss 2006). Their presence in the environment poses a great threat to public 
health and impacts negatively on the aquatic ecosystem. One of the potential sources of the 
lingering PPCPs in the aquatic environment is through the discharge of inadequately treated 
wastewater (Daughton and Ternes 1999; Ternes et al. 2002; Fawell and Ong 2012). Due to the 
partial elimination of these pollutants by wastewater treatment plants, many of the 
contaminants survive and escape from the sewage treatment plants into surface water. 
Some were however retained and adsorbed onto sewage sludge. The sludge which is sometimes 
used by farmers for agricultural soil enrichment also contains emerging pollutants and thus 
represents another way these contaminants get into soil and water. Apart from this, the 
partially metabolized drugs as well as medical care products either in original or altered form 
are equally released into wastewater and later find their way to and through the treatment 
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plants. In spite of the municipal wastewater treatment plants being the most widely known 
source where many of PPCPs and EDCs are released, researchers have also discovered the 
presence of hundreds of EDCs and PPCPs in seawater. This development was ascribed to 
the flow of wastewater effluents by river into various larger water bodies such as the ocean 
(Liu et al. 2010; Joseph et al. 2011). This trend was supported by Richardson and Ternes 
(2005) who observed that more PPCPs exist in the aquatic environment as a result of the 
increasing number of expired drugs presently being discarded in the medical field. The 
resultant harmful effects of some PPCPs are poorly known, bearing in mind they are 
persistent and bioactive, and bioaccumulate in the aquatic environment. PPCPs also 
comprise synthetic hormones, fragrances, shampoos, detergents, analgesics and their 
metabolites, etc. Some of these get introduced into water through industrial and household 
discharge. Although PPCP concentration in the environmental samples is quite low, 
questions were raised regarding their microbial resistance, chemical persistence, and 
the synergistic effects of various compounds (Daughton and Ternes 1999). However, the vast 
majority of people are still ignorant or not aware of the health risk associated with 
exposure to these chemicals. This was evidenced in the survey carried out in United States of 
America where people carelessly disposed expired and unused medicines into sinks and 
toilets instead of returning it to pharmacies (Petrovic et al. 2004). Several studies have shown 
that over 140 PPCPs of different recommended classes were detected in different 
countries (Halling-Sørensen et al. 1998; Daughton and Ternes 1999; Kümmerer and Al-Ahmad 
2010; Heberer 2002; Janex-Habibi et al. 2004; Larsen et al. 2004; Garric and Ferrari 2005; 
Fent et al. 2006). Some of these reports substantiate the concentration range values as well as 
removal rate of PPCPs by the various treatment plants. Quite a large proportion of PPCPs 
have been acknowledged to exist and persist in underground, surface, and drinking water 
as well as municipal sewage sludge across the globe at low concentrations (Kim et al. 2007; 
Focazio et al. 2008; Kinney et al. 2008; Fick et al. 2009; Benotti et al. 2009; Wu et al. 2009; 
McClellan and Halden 2010). This problem has been known for more than a decade, yet little 
progress has been made to stem the tide of such pollutants from entering the global 
waterways. Information on selected representative classes of PPCPs and EDCs most 
frequently found and detected in surface waters, wastewater, and sewage treatment plants is 
shown in Table 1. Some of the PPCPs and EDCs such as bisphenol A, pesticides (e.g., 2, 2,- bis-
p-chlorophenyl-1-1-1-trichloroethane, atrazine), organohalogens (such as furans, 
brominated fire retardants, dioxins) phthalates, polychlorinated biphenyls  ( PCBs),  
and  polycyclic  a ro matic hydrocarbons are more frequently found in wastewater treatment 
plants than in natural environment. 
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Others such as nonylphenol and octylphenol are more prominent in surface and 
groundwater (Esplugas et al. 2007). These chemicals compounds have been established 
to disrupt endocrine systems, yet they are still unregulated and discharge carelessly into 
the immediate environment most especially in the developing countries where there 
is no stringent regulatory and legal frame work. 
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2.1 Sources of Pharmaceuticals, Personal Care Products, and Endocrine 
Disruptors 
The frequency of drugs and medical care products use has continued to increase as a 
consequence of the population growth rate and as such a large quantity of different by-
products is continuously being released into the environment, although at low 
concentrations (Kolpin et al. 2002; Yu and Chu 2009). This concentration level varies 
from country to country depending on the drug consumption, usage pattern, population 
index, and treatment plant potential (Bolong et al. 2009). For instance, the 
concentration of bisphenol A in North American and European water is around 12 and 43 
ppb, respectively (Klecka et al. 2009; Rogers et al. 2013). Ellis (2006) and Czech and 
Rubinowska (2013) asserted that an average of 170 pharmaceuticals in excess of 1 ton 
per year were projected to be used in Brussels. The presence of these contaminants of 
emerging concern has been observed to seriously affect the water quality and obviously 
attract attention with regard to drinking water issues (Heberer 2002; Trussell 2001; Yu and 
Chu 2009). The structural complexity of the compounds was ascribed to their physical and 
chemical properties which have contributed greatly to their prevalent distribution into the 
environment (Rosal et al. 2010). Presently, most of the wastewater treatment plants are not 
designed to effectively treat emerging contaminants. Because of this, a high proportion of 
their metabolites escape and get introduced to aquatic environment as effluents. This 
occurs through physical and chemical breakdown, during disposal and recycling 
operations within wastewater treatment plants (WWTPs). Numerous studies supported 
this claims that wastewater treatment plants and untreated urban wastewater acted are the 
major routes through which PPCPs and EDCs get released into various water sources 
(Barnes et al. 2002; Pryor et al. 2002; Harrison et al. 2006). Subsequently, due to 
their hydrophobic nature, PPCPs and EDCs in water associated with particulate matter and 
hence settle at the bottom sediments and accumulated continuously through 
electrostatic interaction. Apart from WWTP discharges, other sources includes animal 
feeding operations, land-applied bio-solids, row-crop production, on-site wastewater 
disposal systems, recreational activities, transportation or wash-off from roadways, 
and atmospheric deposition (Kidd et al. 2007; Bonefeld-Jorgensen et al. 2007; Palace et al. 
2009; Sellin et al. 2009; Rogers et al. 2013). In the same vein, PPCPs and EDCs come into the 
aquatic environment through the discharge of residual chemicals by householders and by 
agronomy and manufacturing industries (Fig. 1) (Boyd et al. 2003; Bonefeld-Jorgensen et 
al. 2007; Besse et al. 2008; Besse and Garric 2009; Sellin et al. 2009; Kümmerer and Al-
Ahmad 2010; Vulliet and Cren-Olivé 2011; Brausch and Rand 2011; Besse et al. 2012; 
Qin et al. 2012). Houeto et al. (2012) affirmed the presence of metabolized and partially 
metabolized drug residues in various water sources such as wastewater, groundwater, 
surface water, and drinking water. Accidental spills could also be other sources of PPCPs 
and EDCs in the aquatic ecosystems (Falconer et al. 2006; Huang et al. 2008). Personal care 
products enter into the aquatic environments through recreational activities such as 
swimming and also through showering and bathing as well as other technological 
process (Larsson et al. 2007). According to Brooks et al. (2006), the accidental ejection of 
PPCPs and EDCs effluent to ecosystems were responsible for some of the worst-
scenario waterborne diseases that impacted negatively on human health. Boxall et al. 
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(2004) also noted that livestock faeces, residual animal medicine, and aquaculture uses are 
also other routes through which PPCPs and EDCs are being released into the environment. 
Some PPCPs and EDCs enter into the groundwater through leaching and leaking of 
poorly designed sewer and landfills (Fawell and Ong 2012). In a related development, Jackson 
and Sutton (2008)) detected that local sources such as poor sanitary sewer systems at 
different residences, commercial, and industrial locations in California contained a 
high concentration of contaminants such as phthalates, triclosan, and BPA. Jackson and 
Sutton (2008) in their pilot study carried out established the presence of synthetic 
endocrine-disruptors such as phthalates, bisphenol A, and triclosan in the surface waters 
in Oakland, USA. The authors linked the occurrence of the pollutants to the leakage of 
sanitary sewer system. According to Writer et al. (2010), the occurrence of bisphenol A, 17ß-
estradiol, estrone, and 4-nonylphenol in 11 selected lakes in Minnesota, USA, was ascribed to 
land-use activities and lake tropic conditions but not wastewater treatment plants. 
 
 
 
The authors confirmed that the sources of endocrine disruptors are wide spread and 
diverse in nature. In Europe and North America, the occurrence of PPCPs and EDCs in 
rivers and lakes were attributed to poor agricultural practices and sewage effluent. Maletz et 
al. (2013) identified municipal sewage treatment plants, livestock breeding, and hospital 
effluents as the main point sources through which EDCs are introduced into aquatic 
environment. 
 
In emerging and underdeveloped nations such as those in Africa and Asia, careless refuse 
dumping and untreated industrial effluent discharge into waterways are very common. This 
also contributes to the high level of PPCPs and EDCs in aquatic ecosystems (Olujimi et 
al. 2010). The discharge and exposure to small concentration of PPCPs and EDCs were 
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reported to be allied with endocrine gland malfunction, chronic toxicity, and pathogen 
resistance (Rosal et al. 2010). The coverage pattern of PPCPs a n d EDCs manufactured for 
human and animal also differs. The human PPCPs and EDCs behave as pseudo-persistent 
when the effluents were discharged into aquatic systems despite their short 
environmental half-life and are likely to go back into the urban water cycle (Daughton 
2002, 2004; Ankley et al. 2007) while animal drugs are transported to surface waters 
during rainfall or discharged openly in a single quantity to aquatic systems. Some of the 
PPCPs and EDCs later find their way into receiving water systems (Boyd et al. 2003; 
Barnhoorn et al. 2004; Carballa et al. 2004). For instance, in China, municipal wastewater 
discharge was identified as the major contributor of EDCs and PPCPs to riverine water 
(Peng et al. 2008). Also, more than 80 PPCPs and EDCs that were detected according to 
Heberer (2002) originated from reclaimed water used for artificial groundwater recharge. 
Kolpin et al. (2002) in his study established that close to 80 % of 139 streams i n U S w ere 
c ontaminated with antimicrobial agents, fire retardants, steroidal hormones, as well 
as emerging pollutants. Thus, the growing re-use of reclaimed domestic wastewaters for 
irrigation could also be central in low-level PPCPs escaping into urban storm water 
runoff from the irrigated area. Also, Dean (2007) and Lyons (2008) reported 
independently that once the emerging micropollutants are released into the environment 
their harmful effects on the local ecosystems and human residents are unlimited. Yu and 
Chu (2009) attributed the wide occurrence of some PPCPs and EDCs such as ibuprofen, 
bisphenol A, caffeine, triclosan, and bis (2-ethylhexyl) phthalate along the West Prong 
Little Pigeon River, in the USA, to the wastewater discharge into the river. Ortiz de García et 
al. (2013) linked the presence  of  PPCPs  and  EDCs  in  the  natural environment to 
many factors among which were the consumption patterns and water use as well as the 
peculiarity of the wastewater treatment plants. Jin et al. (2004) reported that there have 
been reports of high concentrations of bisphenol A (BPA) in the rivers and marine 
environments in China, although the assessment of BPA has not been extensive especially 
in terms of monitoring data for drinking water. Peng et al. (2008) observed wide occurrence 
of 19 endocrine disrupting pharmaceuticals in urban riverine water of the Pearl River Delta, 
South China. The concentrations of the micropollutants after analysis were discovered to be 
high. The authors ascribed the large presence of pharmaceutically active compounds in 
the river to careless refuse dump and municipal wastewater discharge. 
 
2.2 Environmental Fate and Behavior of PPCPs and EDCs 
Most PPCPs and EDCs are polar and highly hydrophilic with low partition coefficient 
(Kow) and partially soluble in aqueous media. Their presence and bioavailability in the 
aquatic environment depends on the interactions between solids and water in sludge and 
sediment. In some cases, some PPCPs and EDCs concentration in the water was higher. 
This is as a result of series of phase transformations processes involving biodegradation, 
dilution, and photolysis in water environment whereas, in other cases, persistent organic 
pollutants, such as polyaromatic hydrocarbon, or organochlorine pesticides bioaccummulate 
and get adsorbed by the sludge. By and large, it could be inferred that the 
hydrophobicity of a chemical substance will determine whether PPCPs or EDCs will 
bioaccumulate in the solid phase or not (Caliman and Gavrilescu 2009). The more 
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hydrophilic a pollutant is, the higher the tendency of being in the aqueous phase. Therefore, 
one of the most important parameters to be considered for chemical loss during adsorption 
onto sludge is the organic carbon normalized sorption coefficient (KOC). The chemical 
partitioning behavior of PPCPs and EDCs in aqueous media also depends on the partition 
coefficient (Kow). Hence, the greater the values are for both parameters, the more 
those compounds sorb upon organic carbons such as suspended solids, non-polar fats, 
lipids, and mineral oils whereas leaching of PPCPs from the soil or sediment may be 
attributed to low level of KOC  and Kow. The listed mathematical expression may be 
adopted as reference criteria to know if PPCPs or EDCs will be sorbed onto sediment or 
sludge. 
 
(1) if Log KOW <2.5, then it signifies low sorption potential; 
(2) if 2.5<log Kow <4.0, it means medium sorption potential; 
(3) Log KOW >4.0 may be equivalent to high sorption ability (Jones-Lepp and Stevens 2007;  
 
Caliman an d G av ri lesc u 20 09 ) . Ther efo r e, the environmental distribution, 
bioavailability, reactivity, transport phenomenon, and toxicity potential of PPCPs and 
EDCs in natural and artificial ecosystem depends largely on the hydrophilicity and 
hydrophobicity sorption coefficient value of the contaminants (Suarez et al. 2008). 
Some indicative parameters such as estrogenic activity potency (relative to estradiol), 
environmental concentration, half-life, sorption Koc for the environmental fate, and 
behavior of several EDCs and PPCPs are shown in Table 2, which lists some information 
concerning the environmental fate as well as the effects of EDCs and PPCPs. 
 
2.3 Effects of Pharmaceutical and Personal Care Products 
Many nations in the world today are highly concerned about the impending 
environmental crisis and substantial risk occassioned by the occurrence of PPCPs in 
the environment (Bound and Voulvoulis 2005; Glassmeyer et al. 2005; Heberer and 
Feldman 2005; Lishman et al. 2006; Larsson et al. 2007). Although many drugs are 
fashioned to respond to quite a large range of health challenges at low physiological doses 
(milligrams per kilogram), some are more dynamic and can perform best at 
nanograms-per-kilogram concentrations. After accomplishing the specific functions in 
the body, some still interact even at low quantity with multiple non-therapeutic receptors over 
the long-term, resulting in potentially harmful effects on non-targeted receptors in both 
aquatic and terrestrial wildlife. Strauch (2011) asserted that the effects of PPCPS on 
human toxicity irrespective of their concentration in the water supply are yet to be 
ascertained. Research conducted by Ternes et al. (2004) and Topp et al. (2008)) 
discovered that certain PPCPs, such as estrogenic compounds, have a very high 
bioaccumulation potential. 
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This environmental bioaccumulation exacerbates the abnormal hormonal control causing 
reproductive impairments, decreased fecundity, increased incidence of breast and testosterone 
cancers, and persistent antibiotic resistance. This severe, eco-toxic, and prolonged toxicity 
experienced due to the presence of PPCPs in the environment is similar to that of health effects 
caused by the presence of metallic elements detected at concentration below 1 mg/L in 
which the endocrine system are grossly affected (Sharpe and Irvine 2004; Xia et al. 2005; 
Bisceglia and Roberts 2006). Lear et al. (2002) and Hileman (2005) both submitted that 
contamination by certain PPCPs, especially antibiotics, at trace level in water equally 
contribute to the widespread impact and frequent occurrence of antibacterial resistance. 
This rise in antibacterial resistance has overstretched the medical costs of communities 
due to re-occurrence of hospitalization as well increased treatment cost. This is even worse 
in the developing countries where income per day is mostly less than 1 US dollar. Lin et al. 
(2008) revealed that certain fractions of partially metabolized drugs were found in waste 
stream, animal waste, and pharmaceutical effluents, and some of these drugs later undergo 
various degrees of transformation in the aqueous media. 
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During this period, entirely new products that differ with diverse ecotoxicological activity from 
the starting material are formed. The main characteristic property and processes linked to 
the occurrence and fate of the endocrine-disrupting pharmaceuticals are summarized in 
Table 2 below. The fate and behavior of these emerging micropollutants are quite 
diverse and complex depending on the environmental factors. The knowledge on the 
environmental fate of EDCs and PPCPs are still limited. 
 
3 Endocrine-Disrupting Compounds 
Some compounds do obstruct or mimic or antagonize the endocrine system, and these 
substances are known as endocrine-disrupting chemicals. Endocrine systems control a quite 
a large number of body physiological activities such as reproductive processes like 
embryonic development, sex differentiation, and metabolic development (Flint et al. 
2012). Endocrine-disrupting compounds may block the hormonal growth in the endocrine 
system and affect the physiological activities of endogenous hormones (Schug et al. 2011). 
They are alternatively called environmental hormones that cause adverse effects on aquatic 
and terrestrial organisms through altering the metabolism of natural hormones, modifying 
hormones receptor in a cell, interference, or binding to receptors of the endocrine system 
(Jiao and Cheng 2008; Olujimi et al. 2010). EDCs can be natural or man-made. Others 
include alkyl-phenols, dioxins, various drugs, synthetic birth control pills, pesticides, 
plasticizers, and phenolic products (Jackson and Sutton 2008). The exposure of humans to 
endocrine disruptors in recent years has received increased attention due to the high 
exposure rate especially among the aquatic organisms. Ever since, there has been 
increasing concern with regard to the likely impacts of exposure to chemical 
compounds with endocrine-disrupting activity in the environment (Segner 2005; Sumpter 
2005; Game et al. 2006; Mauricio et al. 2006; Xue and Xu 2006; Moder et al. 2007; Shin et 
al. 2007; Hecker and Giesy 2008). In addition, high tendencies of multiplicative and 
evolving abnormalities in infants and children, temporal descending trends in semen 
quality and testosterone levels, and worldwide increased rates of testicular and thyroid 
cancers among adult male populations have been attributed to EDCs exposure (Swan et 
al. 2000; Huyghe et al. 2003; Davies and Welch 2006; Travison et al. 2007; Andersson et 
al. 2007). These reported health cases alerted the scientific and public communities regarding 
the potential risk of environmental EDCs to men’s health. Although the effect of EDCs on 
human health and wildlife biology were first documented in the 1930s, the real research 
progressed in the late 1970s and early 1980s (Vogel 2004; Trenholm et al. 2006; Moder 
et al. 2007). Human beings exposure to EDCs could be through dermal absorption or 
contaminated media such as water, food, air, and soil. To date, no comprehensive list of 
EDCs exists, because most of the new chemicals are being manufactured continuously. There 
is a very limited and incomplete evidence of endocrine-disrupting activity because 
more than 87,000 new chemicals in the market have not been tested for their endocrine 
toxicity (Snyder et al. 2006; Kim et al. 2007). Presently, more than 38,000 chemicals 
and potentially toxic elements have been identified as potential endocrine-disrupting 
pharmaceuticals. This is an indication that more chemicals may be recognized as endocrine 
disrupters as the sum of compounds surges with unanticipated effects (Ferraz et al. 2007; 
Fatoki and O peolu 20 09). This will require identification and elimination of these 
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compounds from the water system. Yet again, this well-documented knowledge of the 
hazards has yet to trigger an adequate precautionary principle approach to control and 
monitoring new compounds before their release into market place and from there into the 
receiving environment. 
 
3.1 Effects of Endocrine-Disrupting Compounds 
The available proof from the relevant literature associated the abnormalities and 
health challenges experienced by aquatic organisms with exposure to low concentration 
of EDCs (nanograms per liter). The toxic impacts of EDCs on the ecosystem have 
continued to be the subject of research and published data in the scientific and public 
health communities over the last 20 years due to the mimicking or disrupting potential 
of the endocrine system (Murray et al. 2001; Thorpe et al. 2003). The effects of these 
emerging micropollutants upon animals are well reported (Table 3), although earlier 
studies stated that there have not been primary effects upon humans and recommended 
further study (Harrison 2001; Sharpe and Irvine 2004). Many synthetic chemicals such as 
pesticides, BPA, and phthalate plasticizers, and indeed estrogens and subordinate plant 
metabolites have been observed to possess endocrine-disrupting properties (Naz 2005). 
Most of these EDCs bind to the cell receptor and antagonize the endocrine glands 
responsible for hormonal secretion. Subsequently, they block the various mechanistic signals 
of the endocrine system and hence modify the hormonal receptor cells (Olujimi et al. 2010). 
Some of the potential endocrine-disrupting PPCPs are shown in Fig. 2. 
 
There are diverse opinions on the effects of EDCs on wildlife and humans; some researchers 
are of the view that there is a link between exposure and effects of EDCs in animals and 
humans while some disputed the claims (Xu et al. 2008). However, studies by Michael 
(2001) discovered that exposure to EDCs have consequential health effects on many aquatic 
species which includes a low sperm count, increasing ovarian, prostate, testicular, breast 
cancer, diabetes/metabolic syndrome, and reproductive failures. These effects of EDCs on 
the natural ecosystem depend on the l ipophil i city increase, e xposure t i m e, and 
biotransformation mechanism. However, some EDCs fail to degrade directly, but instead 
were metabolized into other by-products, even more toxic than the original chemicals, thereby 
increasing their effects on the ecosystem. Information on the aquatic organisms 
affected by exposure to EDCs and PPCPs are shown in Table 3. Human beings and aquatic 
organisms get exposed to PPCPs or EDCs through water, food, soil, or dermal adsorption 
(Olujimi et al. 2010). Burkhardt-Holm et al. (2005) and Kidd et al. (2007) attributed the 
declining rate of fish in freshwater systems to the widespread presence of estrogenic 
chemicals. Safe (2000) also perceived that exposure of aquatic organisms to 
organochlorines led to feminizations of fishes and gulls, and sexual irregularities in 
alligators. In addition, there are increasing occurrences of reproductive and 
developmental abnormalities among infants and children, pregnancy loss, birth defects, 
growth retardation, ovarian failure, low semen quality, and increased rates of testicular and 
thyroid cancers (Swan et al. 2000; Huyghe et al. 2003; Davies and Welch 2006; Travison 
et al. 2007; Andersson et al. 2007; Enewold et al. 2009). These deficiencies occurred as a 
result of exposure to EDCs through oral ingestion such as breast milk, infant formula, 
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contaminated water, food, surface, and carpet dust (Olujimi et al. 2010). This has generated 
concern regarding the potential risk of environmental EDCs to men’s health. Mackenzie et al. 
(2005) and Safe (2000) ascribed the decline in sex ratios in Canada and the United States to 
over exposure to EDCs. With the recently reported cases of adverse health implication 
due to exposure to EDCs, the development of highly efficient technology is necessary in 
order to maintain public health and ecosystem stability (Lee et al. 2003; Braga et al. 2005). 
 
4 Removal of Pharmaceuticals and Endocrine-Disrupting Compounds—An 
Overview 
Despite appropriate legislation framework especially in the advanced nations to check 
inflow of endocrine disruptors and pharmaceuticals into drinking water, the problem still 
persist (Focazio et al. 2008; Swati et al. 2008; Rahman et al. 2009a, b). Efforts were made 
and still ongoing to check mate this ugly trend towards removing or degrading the 
persistent refractory pharmaceuticals and endocrine-disrupting compounds in water and 
wastewater. 
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A number of the conventional wastewater treatment technologies have so far been reported 
in the literature. However, these technologies are not without defects in the removal of 
pharmaceuticals and endocrine disruptors from contaminated water. For instance, 
physicochemical treatment such as activated carbon adsorption (Nowotny et al. 2007; 
Snyder et al. 2007; Yu et al. 2008), reverse osmosis, nanofiltration and (Snyder et al. 
2007) and coagulation–flocculation, and membrane filtration (Snyder et al. 2007; 
Yoon et al. 2007) were discovered not to perfectly remove EDCs and PPCPs. Instead, they 
end up generating other toxic by-products. Nevertheless, an appreciable success was recorded 
when biological and physical treatments were combined, including less generation of by-
products (Zhang et al. 2010). This was evidenced in the study conducted by Al-Rifai et al. 
(2011) when combined activated sludge, microfiltration, and reverse osmosis were used to 
remove 11 pharmaceuticals and two endocrine disruptors in a water recycling process. 
The authors established 97 % removal rate when water concentration was below 0.1 μg/L 
f or most compounds except bisphenol A with concentration above 0.5 μg/L. The 
authors concluded that the combined system did not only efficiently remove the 
micropollutants, but also succeeded in reducing the concentrations of some 
physicohemical parameters. Hence, in order to reduce their concentration to a less harmful 
level, a more sensitive and reliable technology is needed. To date, little or no extensive 
compilation of papers published on the use of combined techniques to degrade 
pharmaceuticals and endocrine-disrupting compounds from wastewater have been 
reviewed. Suffice to mention that most of the reported methods of removing emerging 
contaminants are categorized into three approaches according to Liu et al. (2009); these 
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include physical methods, biodegradation, and advanced oxidation processes. This review 
focused most importantly homogeneous and heterogeneous advanced oxidation processes. 
 
4.1 Advanced Oxidation Processes 
Advanced oxidation processes (AOPs) are very effective techniques capable of 
completely mineralizing the EDCs and PPCPs (Mendez-Arriaga et al. 2008). AOPs are 
chemical oxidation techniques encompassing organic pollutant removal and 
degradation under the influence of highly reactive hydroxyl radicals (Saien and Soleymani 
2007; Saien and Khezrianjoo 2008; Saien et al. 2011). The hydroxyl radical is highly 
reactive and non-selective against refractory organic pollutants with subsequent conversion 
of the pollutants to CO2, H2O, and mineral acids. In the last couple of years, AOPs have 
been extensively exploited and reported in the literature for the degradation of different 
wastewater containing contaminants such as pesticides, pharmaceuticals, endocrine 
disruptors, and dye molecules (Stasinakis 2008; Saien et al. 2011; Machulek Jr et al. 2013). 
AOPs could be generally classified into (1) homogeneous AOPs and (2) heterogeneous 
AOPs. The two categories are reviewed as follows: 
 
Heterogeneous Advanced Oxidation Processes This is defined as a reaction process in which 
semiconductor catalyst dissociated under the influence of photon energy. In this case, the 
catalyst and the reactant exist in different phases. Among the heterogeneous advanced 
oxidation processes is the solid semiconductor TiO2 photocatalyst reviewed below. 
 
4.1.1 Heterogeneous Photocatalysis 
Semiconductor photocatalysis recently emerged technique as one of the advanced 
oxidation processes responsible for degrading recalcitrant, hazardous, and non-
biodegradable substances in wastewater and drinking water into relatively less risky 
products such as CO2, H2O, and inorganic ions. Despite these useful functions, the post-
separation of the used TiO2 photocatalysts from wastewater treatment remains a major 
challenge. Many efforts were geared towards addressing this problem, and such efforts 
included immobilization of TiO2 upon different supports such as silica, perlite, activated 
carbon, clay, zeolites, and many others (Yao et al. 2010). Most of these support materials 
are chosen because of their higher surface area. This is to guarantee highly active reaction 
centers as well as improved light penetration and reflection on the support pores (Friedmann 
et al. 2010; Czech and Rubinowska (2013). Several studies have considered the use of 
titania photocatalysts or the immobilized form of titania to degrade and mineralize 
organic compounds (Nakashima et al. 2003). Some of these are summarized as follows so 
as to give comparative data to the scholars in this area. Due to the enormous availability of 
treatment techniques for contaminants of emerging concern, it is not possible to review all, 
but the review will try to capture advanced oxidation techniques involving singular 
and combined photocatalytic degradation of emerging contaminants. 
 
Chong and Jin (2012) explored the photocatalytic ability of a titanium dioxide (TiO2) 
nanofiber as a pre-treatment technique to degrade carbamazepine using simulated 
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wastewater. The findings revealed that 78 % of CBZ, 40 % of chemical oxygen demand (COD) 
and 23 % o f P O 4 co ncentrations from i nfluent contaminated water were removed 
during the 4-h reaction time. After 0.5-h treatment, the analysis by high-performance 
size exclusion chromatography (HPLC) revealed a dramatic shift of molecular weight from 
higher portion (>10–1,000 kDa) to a lower level (<10 kDa). Tsai et al. (20 09) de scribed 
the photocatalytic degradation of bisphenol A conducted using a TiO2 suspension reactor. 
The degradation capability was evaluated with respect to initial BPA concentration, TiO2 
dosage, initial pH, and temperature. The obtained first-order reaction constants (kobs) 
validated the degradation of BPA during the experiments. The photocatalytic degradation of 
diclofenac, metoprolol, estrone, and chloramphenicol was conducted in a tube reactor using 
different commercially available TiO2 by Czech and Rubinowska (2013). The prepared 
photocatalysts were characterized using BET, X-ray diffraction (XRD), and scanning 
electron microscopy (SEM), and it was observed that anatase TiO2 possessed the highest 
activity in the photocatalytic oxidation of diclofenac, chloramphenicol, and estrone 
whereas the presence of rutile only enhanced the photooxidation of metoprolol. The 
anatase TiO2 with 21 nm crystals was highly efficient  for  COD  reduction  in  the  
treated  water and the photooxidation of all studied pollutants followed pseudo-first-
order kinetics. The photocatalytic degradation of endosulphan and lindane (endocrine- 
disrupting compounds) in the presence of titania was also reported by Ashiya and Guatam 
(2011). The study revealed that the presence of acetone in the reaction mixture slowed the 
reaction competition for hydroxyl radicals between pesticides and  acetone. The 
degradation efficiency of 95 % (endosulphan) and 98 % (lindane) coincided with the zero 
point charge of the catalyst at pH 7. Chong et al. (2011) opined that immobilized anatase 
titanate nanofiber and mesoporous TiO2 infused kaolinite catalysts in a photoreactor (SB-
ASP) were responsible for the CBZ elimination from municipal wastewater. The 
experiment was investigated by varying the following parameters, batch reactor cycles, 
effluent organic matter, nitrate, and phosphate. The analyzed results as obtained from 
high-performance size exclusion chromatography revealed that the carbamazepine 
degradation was achieved. 
 
Tables 4 and 5 below have highlighted clearly the difference between single techniques and 
combined treatment, in most cases, the combination approach appearing to be more 
promising in both organic pollutant elimination and degradation, as most combined 
treatment processes used were able to completely degrade and mineralize EDCs and 
PPCPs above 90 %. This makes the combined system for water reclamation a feasible substitute 
for commercialization in the nearby future. 
 
In another study, photodegradation assisted by TiO2 was conducted for degrading estrone and 
17β-estradiol using sunlight and UV irradiation (Zhang and Zhou 20 08). The study 
confirmed t he use of U V photodegradation to be far more efficient than solar 
irradiation, and this was ascribed to the vigorous absorbance of ultraviolet energy by 
EDCs, although the method did not depend on initial chemical concentration or sample matrix. 
Thus, heterogeneous photocatalysis was confirmed as a very effective method for removal of 
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EDCs from water. Sin et al. (2012) in his review article submitted that heterogeneous 
photocatalysis in the presence of UV, solar light, and oxygen is highly effective for the 
removal and decomposition of EDCs in water. The authors established that the degradation 
efficiency is influenced by solution pH, reaction temperature, light intensity and 
wavelength, catalyst loading, and initial substrate concentration. The study on the adsorption 
and photocatalytic degradation of 15 different pharmaceuticals by titanium dioxide (TiO2) 
anatase and rutile nanowires together with commercially available TiO2 (P25) nanoparticles in 
the presence or absence of UV were investigated by Hu et al. (2012). The UV-exposed 
anatase nanowires effectively mineralized venlafaxin, atorvastatin, ibuprofen, 
naproxen, and gemfibrozil while the effective removal of fluoxetine and norfluoxetine was by 
rutile-phase nanowires. The exposure to 265 nm UV effectively decayed sulfamethoxazole 
and atrazine. The kinetic studies showed that the removals of the pollutants were completed 
within 20–40 min. Rengaraj and Li (2011) established the photocatalytic degradation of 
bisphenol A under UV illumination. Ultrasonic-assisted sol–gel method was used to 
synthesize and characterize Ag-doped titania. The characterization was done using SEM, 
EDX, XRD, XPS, and UV-visible absorption spectroscopy. The loading of Ag on TiO2 
catalysts significantly hastened the photocatalytic oxidation of BPA in aqueous suspension. 
The reaction mechanism specified that the nanosized Ag doped on TiO2 nanocomposites 
acted as the center for electron capture where the reduction of oxygen took place. This reduction 
of oxygen by means of the separation in Ag–TiO2 nanocomposites was responsible for 
the faster BPA degradation rate compared with pure TiO2 particles. Also, Fabiola et al. 
(2008) revealed that the degradation of naproxen in a 0.078 L Duran reactor equipped with a 1 
kW Xe-lamp using TiO2 as photocatalyst did not only confirm photocatalysis treatment as a 
highly efficient technique but recommend further improvement in the biodegradability under 
the operational conditions tested. 
 
However, Zhang et al. (2010) appraised the photocatalytic oxidation of endocrine-
disruptors, Escherichia coliform (Escherichia coli) as well as the estrogenic activity of a 
secondary effluents obtainable from a wastewater treatment plant using a photocatalytic 
reactor coated with TiO2. Filtration followed by photocatalysis was used to compare the 
reduction rate of estrogenic activity and E. coli in both filtered and unfiltered wastewater 
samples. The inactivation rate of E. coli and estrogenic activity improved considerably after 
filtration which was ascribed to the partial removal of suspended solids which thus 
enhanced the photocatalytic oxidation. Combined photocatalysis with filtration pretreatment 
was reported to be effective. Lin et al. (2013) utilized immobilized TiO2 photocatalyst 
supported on a fiberglass to photo mineralize ibuprofen. 
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The authors established direct relationship between photocatalytic dosage and contaminant 
degradation rate. Addition of H2 O2 significantly enhanced the decomposition rate. In 
the same vein, Madhavan et al. (2010) investigated the combined effect of sonolysis, 
photocatalysis, and sonophotocatalysis on the degradation of ibuprofen. The authors 
discovered that the obtained degradation rate from sonophotocatalysis was significantly 
higher than the individual advanced oxidation processes studied. The synergy index value of 
combined advanced oxidation was 0.3 greater than individual sonolytic and 
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photocatalytic process. Equally, Frontistis et al. (2012) reported the efficiency of the 
combined photocatalysis and ultrasonic irradiation regarding 17α-ethynylestradiol 
(EE2) degradation in aqueous solution. The study established a synergistic effect rather than 
a cumulative action between the two combined systems. In fact, increase in catalyst dosage 
and photon flux together with a decrease matrix complexity was responsible for estrogen 
concentration changes. So far, this review has shown that photocatalysis using titania or its 
immobilized form may be useful in degrading and completely mineralizing some of the PPCPs 
and EDCs in contaminated water. 
 
4.1.2 Homogeneous Advanced Oxidation Processes 
Homogeneous advanced oxidation process is a reaction process in which both the 
reactant and photocatalysis are in the same phase. Most of the commonly used 
homogeneous photocatalysis are ozone, metal oxide, metal oxide/hydrogen peroxide, etc. 
The mineralization and decomposition of emerging micropollutants by homogeneous 
advanced treatment therefore exploits ozone, hydrogen peroxide, ultraviolet light, or 
combined process using a combination of ozone and hydrogen peroxide, hydrogen 
peroxide, and ultraviolet light, ozone/ultraviolet light/ferrous ions or ferric ions, 
ferrous or ferric ions/hydrogen peroxide, ferrous or ferric ions/ultraviolet light to degrade 
toxic pollutants. This section review some of the previous research conducted using either 
single or combined system to destroy the contaminants of emerging concern. Xu et al. (2007) 
demonstrated ozone oxidation technique to investigate the degradation of endocrine disruptor 
bisphenol A in drinking water. The effects of different ozone dosages, BPA initial 
concentrations, and ozone adding time were monitored in a reactor. The outcome of the 
study revealed that ozone dosage plays a dominant role during the process of BPA 
degradation, while the impact of the contact time could be ignored, although high ozone 
dosage, and dissolved ozone concentration greatly contributed to the extent of BPA 
degradation. Thus, the O3-H2O2 processes proved to have similar effects on the 
degradation of BPA by ozone oxidation. Li et al. (2011) reported the pentachlorophenol 
(PCP) removal under xenon lamp irradiation in presence of metal oxide bismuth silicate (BSO). 
A mineralization rate of 99.1 % after 120 min was observed. Decrease in pH was observed 
from pH 6.2 to 4.6. The electron spin resonance results indicated that the 
degradation mechanism was largely due to the presence of superoxide radical (O2
−), 
and the GC-MS analysis confirmed the presence of some intermediates, mainly aromatic 
compounds and aliphatic carboxylic acids. Table 2 captures other single treatment 
techniques used to remove and degrade emerging micropollutants. 
 
Furthermore, a review conducted by Ning et al. (2007) showed that the combination of 
ozone and other ozone-based advanced oxidation process were highly efficient in destroying 
steroidal estrogenic hormones such as estrone (E1), 17b-estradiol (E2), estriol (E3), and 
17aethinylestradiol (EE2), except phthalates suspected resist degradation by ozone. 
Pereira et al. (2007) explored two homogeneous advanced oxidation processes such as 
UV and UV/H2O2 to degrade pharmaceutically active substances fond in aqeous water. 
The authors discovered that integration of hydrogen peroxide significantly enhanced the 
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overall degradation efficiency of the pollutants. Hence, combined UV/H2O2 was revealed to 
be a viable option for degradation of the pollutants. Giri et al. (2010) utilized seven 
different advanced oxidation methods such as UV,  UV/TiO2 ,  UV/H2 O2 ,  O3 ,  O3 /UV, 
O3/TiO2, and O3/UV/TiO2 to remove and degrade selected PPCPs in aqueous 
solution. The authors observed four different removal patterns which include non-
degradation by any of the seven techniques, degradation by ozone-based, and not 
ultraviolet, system, degradation by ultraviolet, and not ozone-based, techniques. In 
addition, the degradation of the pollutants by combined ozonation and ultraviolet was rapid 
and efficient. Zelmanov and Semiat (2008) demonstrated that iron(III) oxide 
nanocatalyst combined with hydrogen peroxide could effectively degraded water 
contaminated with phenol and ethylene glycol without necessarily exposing the solution to 
ultraviolet or photolight. The authors concluded that the degradation rate of phenol and 
ethylene glycol was 35 times and two to four times greater than the literature value 
reported for Fenton process and UV. Kim et al. (2009) reported that H2O2 addition aided 
the photodegradation of PPCPs during UV treatment and found that the average first-order 
rate constant value for all the PPCPs studied increased by a factor of 1.3 when H2O2 was 
added during UV treatment. The addition of H2O2 improved the photodegradation rates of 
PPCPs appreciably during UV treatment. Equally, Nakonechnya et al. (2008) explored 
ozone and hydrogen peroxide combination to degrade steroidal hormone estrone (E1). The 
authors observed that the E1 degradation was found to depend on pH and O3/H2O2 
ratio. Thus, the combination of O3/H2O2 proved to be highly efficient treatment for E1. 
Lopez et al. (2003) argued that UV and UV/H2O2 treatment methods were able to oxidize 
pharmaceutical intermediates such as 5-methyl-1,3,4-thiadiazole-2-methyl thiol ( 
MMTD-Me) w hile the d irect photodegradation of the two pharmaceutical intermediates 
have shown that the intermediate with lower concentration degraded faster. Vogna et al. (2004a) 
proposed diclofenac oxidation using combined UV/H2O2 and ozonation technique and were 
found to be feasible and viable in bringing about complete mineralization of diclofenac. In 
another study, the UV/H2O2 method was effective in removing carbamazepine while UV 
alone was not efficient to reduce the carbamazepine concentration (Vogna et al. 2004b.) 
 
However, other AOPs such as ultrasonic irradiation with widespread application of 
degrading organic pollutants present in wastewater have equally been examined 
(Shannon et al. 2008). These methods oxidize the complex organic matter found to 
be extremely difficult to degrade biologically into simpler end products. The reported 
complete degradation and mineralization potential was ascribed to the reactive nature of 
the generated free active species most predominantly hydroxyl radical (Giri et al. 
2010). The radical was reported to be non-selective and highly reactive with higher oxidation 
potential of 2.33 V when compared with other conventional oxidizing agents such as H2O2 
or KMnO4 (Gogate and Pandit 2004). Xiao et al. (2013) combined continuous wave (CW) 
and pulsed wave (PW) ultrasound to degrade carbamazepine, ibuprofen, acetaminophen, 
sulfamethoxazole, ciprofloxacin, propyl gallate, and diethyl phthalate. The findings showed 
that degradation rates of the pollutants were quicker for smaller compounds but less rapid for 
larger compounds by PW ultrasound than that achieved under CW ultrasound. The 
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introduction of hydroxyl radical trapping agent, acetic acid, to PPCPs solutions aided in 
degrading certain fractions within the bulk solution that were positively interrelated with the 
molar volume of the compound. Chong et al. (2012) joined an integrated membrane bioreactor 
with titanium dioxide photocatalyst (MBR-TiO2) to mineralize CBZ from pharmaceutical 
wastewater. The individual systems of MBR and TiO2 photocatalytic technology were 
monitored separately so as to establish the synergistic operational effects. The respirometric 
test showed that CBZ introduction acts as a chemical stressor that influenced the biomass 
metabolism in the MBR which resulted in the reduction of sludge yield. The combined MBR-
TiO2 system operated at 4:1 ratio condensed the chemical stressor effects and a maximum of 
95 % CBZ removal efficiency was observed. However, despite the success story of efficient 
degradation of emergent contaminants by credited to various advanced oxidation processes, 
high operational cost still limits it widely acceptance especially in the emergent nations. 
Therefore, the integration of less expensive treatment process such as adsorption with 
advanced oxidation process will further enhance and accelerate the degradation rate of 
organic pollutants. 
 
4.1.3 Combined Advanced Oxidation Processes with Biological and Physical Treatment 
As stated earlier, wastewater treatment containing organic pollutants is complex, 
expensive, and time-consuming. The survey of literatures revealed that most wastewater 
treatment plants are not designed for emergent pollutants removal. Therefore, a more 
practical, versatile, and economical technique is needed. Ever since the identification and 
detection emergent micropollutants in terrestrial and aquatic environment, numerous 
treatment processes such as biological and physicochemical methods have been exploited 
and explored. However, AOPs and other conventional treatment option such as 
physicochemical treatment have been applied to remove pharmaceuticals and endocrine 
disruptors from wastewater. Advanced oxidation process coupled with biological process 
is not often effective against the target pollutants degradation due to the inhibitory 
effect of hydroxyl radicals by the biomass. The physical treatment such as filtration can be 
employed before or after the advanced oxidation process. Thus, the application of physical and 
biological methods helps to remove large insoluble particles, reducing turbidity and 
interfering ions from the aqueous matrix. Once all these are removed, the degradation 
efficiency of AOPs will be improved. An overview on the combined AOPs with physical or 
biological treatment is as follows. Ozonation as one of the AOPs is employed as a pre-
oxidation step in a combined treatment line. The combination of ozonation and a moving-bed 
biofilm reactor to remove estrogenic substances from a conventional activated-sludge 
treatment was reported by Gunnarsson et al. (2009). Ozonation was used as a pre-treatment 
step to enhance anaerobic digestion  stability  of the  modelled compounds (Carballa 
et al. 2007). Not only that, chemical oxygen demand solubilization of 60 % was achieved, 
thus hastening the destruction of the soluble organic matter during anaerobic digestion. Also, 
photo-Fenton process was integrated with a biological system to degrade α-
methylphenylglycine by Oller et al. (2007a). It was observed that the combined system 
enhanced the biodegradability and broad elimination of bio-refractory compound (Oller et 
al. 2007). The coupled technology was able to remove 95 % of total organic carbon (Oller et 
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al. 2011). José et al. (2010) reported that the removal of carbamazepine, clofibric acid, 
diclofenac, and diazepam from municipal wastewater using biological treatment 
failed to completely eliminate the pollutants, but incorporation of membrane bioreactor 
and advanced oxidation processes such as O3, O3/UV, O3/H2O2, and UV/H2O2 effectively 
achieved complete removal. Nakada et al. (2007) studied the removal of some 
pharmaceuticals and endocrine disruptors present in municipal wastewater by 
combined sand filtration and ozonation. It was stressed that the combined efforts of ozone 
and sand filtration with sludge treatment enhanced the elimination of 80 % of the model 
pollutants. Ozonation was noted to play the dominant role. In another study, combined 
advanced oxidation and a biological treatment process was used to remove pesticides 
from an aqueous matrix. It was observed that the biological treatment assisted in removing 
the bulk of the chemical oxygen demand while O3/UV enhanced the pesticide decomposition 
(Lafi and Al-Qodah 2006). Rossnera et al. (2009) utilized three different adsorbents such as 
activated carbon, carbonaceous resin, and high-silica zeolite to remove EDCs, PPCPs, and 
flame retardant. Activated carbon was only able to achieve a two-log elimination of the 
modelled compounds. The incorporation of advanced oxidation processes enhanced 
the degradation rate. Badawy et al. (2009) utilized combined Fenton and biological 
treatment process to eliminate some pharmaceuticals from industrial wastewater. The 
authors revealed that recalcitrant toxic pollutants were partially removed by biological 
treatment and successfully destroyed by the Fenton process. Thus, the integrated system is 
more advantageous and capable of completely eliminate hazardous persistent pollutants in 
water and wastewater. 
 
Liu et al. (2009) reviewed the removal mechanism of endocrine disruptors in wastewater 
treatment using three different methods such as physical, biodegradation, and chemical 
advanced oxidation processes. The authors recognized that physical and advanced 
oxidation processes such as ozone/hydrogen peroxide are more advantageous with respect 
to removal and degradation efficiency while a biodegradation process among which activated 
sludge treatment was observed to reduce the level of EDCs in surface water. Hence, 
physical, biological, and chemical advanced oxidation could be combined to improve the 
removal performance of EDCs. 
 
5 Detection and Quantification of Emerging Micropollutants 
The contaminants of emerging concern are structurally complex, and the probability of being 
highly present in drinking water is increasing due to ever-increasing population density 
driven by high demand of new chemicals in the market (Marchesini et al. 2007). There is a 
need to urgently adopt fast and sensitive analytical protocols that can screen, detect, and 
quantify a large diversity of composites concurrently. This becomes necessary as the 
various known analytical equipment including liquid chromatography combined with mass 
spectrometry (LC-MS), high-performance-liquid chromatography (HPLC), liquid 
chromatography coupled with electrochemical detection (LC-ED), capillary 
electrophoresis (CE), and gas chromatography coupled with mass spectrometry (GC-MS) used 
so far are not without some challenges (Gatidou et al. 2007; Comerton et al. 2009; Mottaleb 
et al. 2009). Presently, most of these instruments are too cumbersome in analyzing 
http://repository.uwc.ac.za
25 
 
samples, and despite the long sample pre-treatment, the equipment can only detect or 
identify a small range of similar contaminant at a time in the matrices. Apart from this, long pre-
concentration steps, lack of rapid processing and detection of sample, and time-consuming 
analysis negates the continuous use of these analytical instruments. Also, lack  of  portability and 
suitability during field work constitute another challenge (Huertas-Perez and Garcia-Campana 
2008; Blazkova et al. 2009; Le Blanc et al. 2009). Not only these, the sophisticated and costly 
nature of the equipment, their labor–energy-intensive nature coupled with the need of the 
derivatization of samples in the case of (GC-MS) prior to analysis form the basis to develop more 
simple and robust instrumental techniques that are affordable, durable, and easy to maintain. 
Sensors and biosensors are presently seen as a replacement to those aforementioned 
instruments. Iwuoha (2012) established that sensor materials were more sensitive in determining 
and quantifying the emerging micropollutants than other reported analytical equipment such as 
GC-MS. Sensors and biosensors, for instance, are presently considered as an alternative to those 
aforementioned expensive instruments due to the ease of operation and elimination of the pre-
treatment steps, lower consumption time, higher sensitivity, and fast responses (Yin et al. 2009). 
Other benefits include easy determination of pollutants in multifaceted media without 
rigorous sample preparation (Rodriguez-Mozaz et al. 2006). Presently, large numbers of 
biosensors developed are still in the laboratory stage and need to be certified before bulk 
manufacture and use (Rodriguez-Mozaz et al. 2006; Farré et al. 2009).  Apart  from  providing  
information on the chemical composition of the sample, biological activity such as toxicity and 
endocrine-disrupting effect can also be obtained. The development of more sensors and 
biosensors should be the top priority in the nearest future. This should be standardized for easy 
detection and quantification of emerging micropollutants. Without functional and 
practicable analytical tools, determination, and quantification of the environmental fate, and 
behavior of these emergent pollutants will be a mirage. However, despite the simplicity in the 
use of biosensors to detect EDCs and PPCPs, one major challenge is that biosensors is specific 
and can  only sense a micropollutant at a time. This mean a lot of biosensors need to be 
developed which will require additional cost  and time. Therefore, simple analytical technique  
such  as  total  organic  carbon  (TOC)  is recommended as a high level of TOC in water or 
wastewater signifies huge pollutants load. Hence, the water or wastewater necessitates 
treatment. 
 
6 Conclusion and Recommended Interventions 
Advanced oxidation processes can degrade these contaminants without necessarily 
adding complex chemicals. This is a much green and less complex route than many other 
options, if energy consumption can be reduced. Although free radicals are short-lived and do 
the job rapidly without leaving long-term residues when applied properly but need to be 
managed so as not to leave partially degraded secondary pollutants. The continuous 
reported adverse health challenges occasioned by poor or partial elimination and 
degradation of emerging micropollutants by single treatment techniques in drinking 
water also require urgent interventions. This means that the current single treatment system 
has failed to do the job and instead of detoxifying the contaminants acts as a point source of 
environmental contamination. The removal of PPCPs/EDCs from contaminated water is 
a challenging task due to the complexity and persistence of the pollutants in water. Thus, 
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there is a need to urgently adopt the use of combined advanced oxidation techniques 
to treat wastewater contaminated by emerging pollutants. Combined advanced 
oxidation techniques offer the potential to drastically reduce the health and environmental 
effects of persistent organic pollutants and endocrine disruptors. Hence, the new 
approaches will help to maintain public health together with environmental sustainability. 
The combined technology offers the hope that adequate water purification will not only 
contribute to the production of safer water for drinking purpose but also eliminate the re-
surfacing of by-products after single-stage wastewater treatments. This will go a long 
way to putting to rest the issue of heightened fears concerning the safety of drinking water. 
Not only this, the task of water regulatory agencies will also become less onerous with regards 
the treatment of the contaminated water. Emerging micropollutants are now recognized as 
a problematic issue due to their bioaccumulation in the environment owing to their 
accidental discharge. A lot still needs to be done, among which is the establishment of 
monitoring teams to enforce the environmental regulations. There is also a great need to 
continuously carry out a thorough routine toxicological analysis of drinking water so as to 
establish the exposure limits to PPCPs/EDCs in humans. Water regulatory agencies need to 
be informed of the proper treatment technique to adopt while treating tainted wastewater. 
Future research should also include re-designing and upgrading conventional wastewater 
treatment plants in urban centers to accommodate the latest technology of degrading 
and mineralizing emerging pollutants. This will contribute in no small measure to the 
quality of drinking water. The research on emerging contaminants should be extended to the 
developing countries where the extent of the deterioration of water sources needs to be 
established, which will aid the water industry and the policy makers to choose the appropriate 
advanced water treatment techniques to use for degrading PPCPs/EDCs in water. Biosensors 
need to be further developed for rapid detection of specific contaminants. In order to have 
a natural ecosystem that is completely free of pharmaceuticals and endocrine-disrupting 
compounds, there is a need to introduce green chemistry in the production and 
development of numerous drugs, medical, and personal care products that are affordable 
and do not persist in the environment. A regulatory framework based on the precautionary 
principle should be implemented to screen all compounds for their ecotoxicity prior to 
approval for use. 
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